Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease

Completed

• Conditions: Pulmonary Disease, Chronic Obstructive
• Interventions: Drug: inhaled bronchodilator

• Registration Number: NCT02176564
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

A pharmaco-epidemiological, observational study that aimed at assessing in a prospective manner the evolution of Quality of Life (QOL) in chronic obstructive pulmonary disease (COPD) patients treated with inhaled bronchodilators

Detailed Description

Not available

Study Timeline

• Study Start: 1999-06
• Primary Completion: 2000-10
• Status Verified: 2014-06
• Study First Submitted: 2014-06-26
• Study First Submitted QC: 2014-06-26
• Study First Posted: 2014-06-27
• Last Update Submitted: 2014-07-17
• Last Update Posted: 2014-07-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2639

Inclusion Criteria

• Diagnosis of COPD confirmed by Pulmonary Function Test (PFTs)
• Recent treatment with a free or fixed association of inhaled bronchodilators

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Chronic obstructive pulmonary disease	inhaled bronchodilator	Patients with COPD treated with inhaled bronchodilators

Primary Outcome Measures

Name	Time	Method
Assessment of health-related quality of life (Short-Form Health Survey)	4 months